持田製薬の新中期経営計画で知財戦略はどう変わるか？

持田製薬が2025 年5月13日発表した中期経営計画「25-27中計」の内容とそれに対する投資家・業界関係者・メディア・アナリストからの評価をDeep Researchに調査させ、この新中期経営計画により、持田製薬の知財戦略はどう変わるかをDeep Researchに予測させました。ご参考まで。
 
持田製薬グループ「25-27 中期経営計画」について
https://finance-frontend-pc-dist.west.edge.storage-yahoo.jp/disclosure/20250512/20250512540704.pdf
 
NotebookLM音声概要（6分28秒）
https://notebooklm.google.com/notebook/66271c85-a888-4e6c-8882-c87cdcc406e8/audio
 
 
How Will Mochida Pharmaceutical's Intellectual Property Strategy Change Under Its New Medium-Term Management Plan?
 
I asked Deep Research to examine the content of Mochida Pharmaceutical’s newly announced medium-term management plan "25–27 Plan," released on May 13, 2025, as well as the evaluations from investors, industry professionals, media, and analysts. Based on this, Deep Research provided forecasts on how Mochida Pharmaceutical’s intellectual property strategy is expected to change under the new plan. For your reference.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.

Your browser does not support viewing this document. Click here to download the document.